Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Results
-
ADDING and REPLACING First All Female-Founded Investment Platform, LUXUS, Gives Investors Opportunity to Invest in Rare Diamonds and Gems
-
First All Female-Founded Investment Platform, LUXUS, Gives Investors Opportunity to Invest in Rare Diamonds and Gems
-
Cantor Fitzgerald Reiterates Overweight Rating, $18 Price Target on Aravive (ARAV), "Peak Sales Potential of AVB-500 Remains Underappreciated"
-
SILVERSTEIN PROPERTIES ACQUIRES FLORIDA DEVELOPMENT SITE FROM 1754 PROPERTIES AND TRIANGLE CAPITAL GROUP
-
Cantor Fitzgerald Reiterates Overweight Rating. $5 Price Target on Cidara Therapeutics (CDTX), "We Believe Street Under-appreciated Sales Potential of CDTX's Two Pipeline Assets"
-
Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
-
Cantor Fitzgerald Maintains ProQR Therapeutics N.V. (PRQR) at Overweight with $3.50 Price Target
-
Orchid Island Capital Announces May 2022 Monthly Dividend and April 30, 2022 RMBS Portfolio Characteristics
-
Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial Results
-
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
-
Westwater Resources, Inc. Announces Results for First Quarter Ended March 31, 2022
-
Form 13F-HR/A CANTOR FITZGERALD INVEST For: Mar 31
-
Cartesian Growth Corporation II Announces Closing of $230 Million Initial Public Offering
-
Cartesian Growth Corporation II Announces Closing of $230 Million Initial Public Offering
-
Curaleaf (CURLF) PT Lowered to $14.60 at Cantor Fitzgerald
-
'Welcome Relief': 3 Analysts Discuss Pfizer's $11.6 Billion Deal to Acquire Biohaven (BHVN)
-
Biotech Acquisition (BIOT) and Blade Therapeutics Announce Effectiveness of Registration Statement, Signs $75M Committed Equity Financing
-
Depoliticizing Corporate America: Strive Asset Management Launches To Advance Excellence Capitalism Over ‘Stakeholder Capitalism’
-
Biotech Acquisition Company and Blade Therapeutics, Inc. Announce Effectiveness of Registration Statement on Form S-4, Date of BAC's Extraordinary General Meeting to Approve Proposed Business Combinat
-
Best Marijuana Stocks To Watch This Week In May
-
RedHill Biopharma (RDHL) Announces 10.57M ADS Direct Offering at $1.42/ADS
-
RedHill Biopharma Announces $15 Million Registered Direct Offering with a Leading Healthcare Investor
-
Form 40-17G CANTOR FITZGERALD SUSTAI
-
Cartesian Growth Corporation II (RENEU) Prices 20M Unit IPO at $10/unit
-
Analysis: Buckle up, say traders as Wall Street's wild ride shows no sign of end
-
Cartesian Growth Corporation II Announces Pricing of $200 Million Initial Public Offering
-
Cartesian Growth Corporation II Announces Pricing of $200 Million Initial Public Offering
-
Form 8-K Cantor Fitzgerald Income For: May 02
-
Form 4 Cantor Fitzgerald Income For: May 02 Filed by: LUTNICK HOWARD W
-
Cantor Fitzgerald Reiterates Overweight Rating on SeaSpine Holdings (SPNE) Following Q1 Report, Sees "Likely Share Price Appreciation"
-
Form 424B3 Cantor Fitzgerald Income
-
Sono Motors Announces Closing of Follow-on Offering
-
Sono Motors Announces Closing of Follow-on Offering
-
Pfizer (PFE) Sales Beat Estimates on Robust Covid Vaccine Sales; Analyst Weigh In on Results
-
Satellogic Announces Full Year 2021 Financial Results
-
Cantor Fitzgerald Reiterates Overweight Rating, $85 Price Target on Cutera (CUTR)
-
springbig and Tuatara Capital Acquisition Corporation Announce Amendments to Business Combination to Enhance Transaction for Public Shareholders and Additional Funding Through a Convertible Note and C
-
Form 10-K/A Cantor Fitzgerald Income For: Dec 31
-
UPDATE: Cantor Fitzgerald Downgrades Emergent BioSolutions (EBS) to Neutral
-
Sono Group (SEV) Prices 10M Share Follow-on Offering at $4/sh
-
UPDATE: Cantor Fitzgerald Starts Roivant Sciences (ROIV) at Overweight
-
Sono Motors Announces Pricing of Follow-on Offering
-
Sono Motors Announces Pricing of Follow-on Offering
-
Field Trip Health Ltd. Announces Intention to Separate the Field Trip Discovery and Field Trip Health Divisions Into Two Independent Public Companies
-
Cantor Fitzgerald Reiterates Overweight Rating, $21 Price Target on SeaSpine Holdings (SPNE)
-
Orchid Island Capital Announces First Quarter 2022 Results
-
Cantor Fitzgerald Reiterates Overweight Rating, $12 Price Target on Lucid Diagnostics Inc (LUCD) on BeiGene's RATIONALE 306 Trial Data, "Encourage Investors to Acquire LUCD Shares at an Attractive Ent
-
SoundHound Announces Closing of Business Combination
-
Veru (VERU) and Opiant (OPNT) Top Cantor Fitzgerald's List of Largest Short Interest Increases

